Yilin Wu

699 citations
44 papers · 431 indexed · h-index 11
Topics
Liver Disease Diagnosis and Treatment (4 papers)Cancer-related molecular mechanisms research (3 papers)Cancer Genomics and Diagnostics (3 papers)
Partner nations
ChinaTaiwanUnited States

In The Last Decade

Yilin Wu

42 papers receiving 429 citations

Peers

Yilin Wu
Comparison fields: 5 of 82
  • Molecular Biology 191
  • Cancer Research 123
  • Immunology 70
  • Epidemiology 67
  • Oncology 61
Replace Weixue Tang with:
Weixue Tang China
Changming Xie China
Jietao Lin China
Yoshimi Kakiuchi Japan
Dan He China
Liangying Ye China
Yansong Pu China
Huynh Cao United States
Lijin Zhao China
Yilin Wu relative to Weixue Tang China Weixue Tang's profile →
Citations per field
00.5×7.5×
Weixue Tang · 1×
Citations per year

Countries citing papers authored by Yilin Wu

Since Specialization
Citations

This map shows the geographic impact of Yilin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yilin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yilin Wu more than expected).

Fields of papers citing papers by Yilin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yilin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yilin Wu. The network helps show where Yilin Wu may publish in the future.

Co-authorship network of co-authors of Yilin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yilin Wu. A scholar is included among the top collaborators of Yilin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yilin Wu. Yilin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 1
3 1
4 2
5 3
6 2
7 9
8 3
9 4
10 7
11 3
12 15
13 98
14 4
15 11
16 1
17
Patterns and Predictors of First-Line Therapy Use Among Newly Diagnosed Multiple Myeloma Patients Ineligible for Stem Cell Transplant in an Integrated Healthcare System
1
18 37
19 4
20
La coscoja (Quercus coccifera L.): ecología, características y usos
2

About Yilin Wu

Yilin Wu is a scholar working on Cancer Research, Hematology and Public Health, Environmental and Occupational Health, having authored 44 papers that have together received 431 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (4 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Cancer Research (123 citations), Immunology (70 citations) and Hepatology (26 citations). Yilin Wu has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Yingxia Wang, Hui Ding, Hong Wu, Guo‐Chao Zhong, Mei Wang, Jing Jiao, Jianping Gong, Yue Yu, Xiaohui Zhang and Wenfeng Zhang. Their work appears in journals such as Advanced Materials, Nature Communications and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026